Venus Remedies (BOM:526953) 3-Year EBITDA Growth Rate : 22.10% (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Venus Remedies 3-Year EBITDA Growth Rate?

Venus Remedies's EBITDA per Share for the three months ended in Dec. 2023 was ₹10.78.

During the past 12 months, Venus Remedies's average EBITDA Per Share Growth Rate was 47.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 22.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 19.00% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -8.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Venus Remedies was 35.50% per year. The lowest was -31.90% per year. And the median was 8.85% per year.

Competitive Comparison of Venus Remedies's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Venus Remedies's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Venus Remedies's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Venus Remedies's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Venus Remedies's 3-Year EBITDA Growth Rate falls into.

Venus Remedies 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Venus Remedies (BOM:526953) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Venus Remedies 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Venus Remedies's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Venus Remedies (BOM:526953) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Venus Remedies Ltd (BOM:526953) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

VENUSREM:India

Address

Plot 51-52, Industrial Area, Phase 1, Panchkula, HR, IND, 134113

Website

https://www.venusremedies.com

Venus Remedies Ltd is an Indian drug manufacturer. It is engaged in manufacturing and trading pharmaceutical products. The company produces biologically active food supplements which include food supplements are natural complexes containing minerals, vitamins, dietary fibers, extracts of medicinal herbs, amino acids, and others.

Venus Remedies (BOM:526953) Headlines

No Headlines